Dr. Ayaz Matin, MD

Dr. Matin practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Matin's NPI, 1801087978, was assigned on August 5, 2007. Dr. Matin holds Pennsylvania license MD432229.

Dr. Matin's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Matin's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Matin is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Matin to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matin practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Matin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Matin's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 733 Medicare services from Dr. Matin across 18 procedure codes in 2024, for 437 Medicare patients. Medicare paid $80,520 for them.

CMS counts 437 Medicare patients who saw Dr. Matin in 2024. The largest group is 65 to 74, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matin's median patient age at 65, with 53% women.

In 2024, Dr. Matin wrote 792 Medicare Part D claims for 212 patients. 86% of them were for generic drugs. CMS names the drug for 668 of them, across 12 drugs with 11 or more claims each, at $75,196 in total drug cost. In 2023, CMS named 656 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Matin for performance year 2024, reported through an alternative payment model (APM). Dr. Matin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Matin as offering telehealth. CMS counts 494 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Matin, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Matin, published from 2020 to 2023. 2020 was the busiest year, with 2. The most frequent topics are COVID-19. Dr. Matin has published most often in Am J Case Rep. Dr. Matin's most frequent co-authors are Hammad B. Liaquat, MD, Gil Ignacio Ascunce, MD and Krishna Vallabhbhai Bodrya.

CMS Open Payments shows 170 general payments to Dr. Matin from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Boston Scientific Corporation paid the most, $6,730.